Literature DB >> 20621039

Tumor oncogenotypes and lung cancer stem cell identity.

James P Sullivan1, John D Minna.   

Abstract

In this issue of Cell Stem Cell, Curtis et. al. (2010) reveal that the identities of lung cancer stem cell populations differ depending on the specific tumor oncogenotype in three murine lung adenocarcinoma models. These findings highlight the importance of determining the cancer stem cell oncogenotype for genotypically diverse malignancies. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID： 20621039      PMCID： PMC3374716          DOI： 10.1016/j.stem.2010.06.005

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  10 in total

1.  Identification of bronchioalveolar stem cells in normal lung and lung cancer.

Authors:  Carla F Bender Kim; Erica L Jackson; Amber E Woolfenden; Sharon Lawrence; Imran Babar; Sinae Vogel; Denise Crowley; Roderick T Bronson; Tyler Jacks
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

2.  Primary tumor genotype is an important determinant in identification of lung cancer propagating cells.

Authors:  Stephen J Curtis; Kerstin W Sinkevicius; Danan Li; Allison N Lau; Rebecca R Roach; Raffaella Zamponi; Amber E Woolfenden; David G Kirsch; Kwok-Kin Wong; Carla F Kim
Journal:  Cell Stem Cell       Date:  2010-07-02       Impact factor: 24.633

3.  Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.

Authors:  Jeff C Liu; Tao Deng; Rajwinder S Lehal; Jinny Kim; Eldad Zacksenhaus
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

4.  Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion.

Authors:  Jennifer Shepard Dovey; Sima J Zacharek; Carla F Kim; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

Review 5.  Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy.

Authors:  James P Sullivan; John D Minna; Jerry W Shay
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

6.  Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.

Authors:  K A Kwei; Y H Kim; L Girard; J Kao; M Pacyna-Gengelbach; K Salari; J Lee; Y-L Choi; M Sato; P Wang; T Hernandez-Boussard; A F Gazdar; I Petersen; J D Minna; J R Pollack
Journal:  Oncogene       Date:  2008-01-21       Impact factor: 9.867

Review 7.  Lung cancer in never smokers--a different disease.

Authors:  Sophie Sun; Joan H Schiller; Adi F Gazdar
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

8.  Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.

Authors:  Robert W Cho; Xinhao Wang; Maximilian Diehn; Kerby Shedden; Grace Y Chen; Gavin Sherlock; Austin Gurney; John Lewicki; Michael F Clarke
Journal:  Stem Cells       Date:  2007-11-01       Impact factor: 6.277

9.  Somatic mutations affect key pathways in lung adenocarcinoma.

Authors:  Li Ding; Gad Getz; David A Wheeler; Elaine R Mardis; Michael D McLellan; Kristian Cibulskis; Carrie Sougnez; Heidi Greulich; Donna M Muzny; Margaret B Morgan; Lucinda Fulton; Robert S Fulton; Qunyuan Zhang; Michael C Wendl; Michael S Lawrence; David E Larson; Ken Chen; David J Dooling; Aniko Sabo; Alicia C Hawes; Hua Shen; Shalini N Jhangiani; Lora R Lewis; Otis Hall; Yiming Zhu; Tittu Mathew; Yanru Ren; Jiqiang Yao; Steven E Scherer; Kerstin Clerc; Ginger A Metcalf; Brian Ng; Aleksandar Milosavljevic; Manuel L Gonzalez-Garay; John R Osborne; Rick Meyer; Xiaoqi Shi; Yuzhu Tang; Daniel C Koboldt; Ling Lin; Rachel Abbott; Tracie L Miner; Craig Pohl; Ginger Fewell; Carrie Haipek; Heather Schmidt; Brian H Dunford-Shore; Aldi Kraja; Seth D Crosby; Christopher S Sawyer; Tammi Vickery; Sacha Sander; Jody Robinson; Wendy Winckler; Jennifer Baldwin; Lucian R Chirieac; Amit Dutt; Tim Fennell; Megan Hanna; Bruce E Johnson; Robert C Onofrio; Roman K Thomas; Giovanni Tonon; Barbara A Weir; Xiaojun Zhao; Liuda Ziaugra; Michael C Zody; Thomas Giordano; Mark B Orringer; Jack A Roth; Margaret R Spitz; Ignacio I Wistuba; Bradley Ozenberger; Peter J Good; Andrew C Chang; David G Beer; Mark A Watson; Marc Ladanyi; Stephen Broderick; Akihiko Yoshizawa; William D Travis; William Pao; Michael A Province; George M Weinstock; Harold E Varmus; Stacey B Gabriel; Eric S Lander; Richard A Gibbs; Matthew Meyerson; Richard K Wilson
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

10.  SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.

Authors:  Adam J Bass; Hideo Watanabe; Craig H Mermel; Soyoung Yu; Sven Perner; Roel G Verhaak; So Young Kim; Leslie Wardwell; Pablo Tamayo; Irit Gat-Viks; Alex H Ramos; Michele S Woo; Barbara A Weir; Gad Getz; Rameen Beroukhim; Michael O'Kelly; Amit Dutt; Orit Rozenblatt-Rosen; Piotr Dziunycz; Justin Komisarof; Lucian R Chirieac; Christopher J Lafargue; Veit Scheble; Theresia Wilbertz; Changqing Ma; Shilpa Rao; Hiroshi Nakagawa; Douglas B Stairs; Lin Lin; Thomas J Giordano; Patrick Wagner; John D Minna; Adi F Gazdar; Chang Qi Zhu; Marcia S Brose; Ivan Cecconello; Ulysses Ribeiro; Suely K Marie; Olav Dahl; Ramesh A Shivdasani; Ming-Sound Tsao; Mark A Rubin; Kwok K Wong; Aviv Regev; William C Hahn; David G Beer; Anil K Rustgi; Matthew Meyerson
Journal:  Nat Genet       Date:  2009-10-04       Impact factor: 38.330
  10 in total
  9 in total

1.  Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.

Authors:  Jens U Marquardt; Chiara Raggi; Jesper B Andersen; Daekwan Seo; Itzhak Avital; David Geller; Yun-Han Lee; Mitsuteru Kitade; Agnes Holczbauer; Matthew C Gillen; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2011-07-27       Impact factor: 17.425

2.  Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells.

Authors:  Edward Kai-Hua Chow; Ling-ling Fan; Xin Chen; J Michael Bishop
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

Review 3.  Novel insights into the molecular origins and treatment of lung cancer.

Authors:  James D Webb; M Celeste Simon
Journal:  Cell Cycle       Date:  2010-10-11       Impact factor: 4.534

4.  A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells.

Authors:  Satya Prakash Shukla; Aaron Raymond; Vineeta Rustagi; Samanth R Kedika; Olivia Tran; Liye Wang; Bin Guo; D Gomika Udugamasooriya
Journal:  Bioorg Chem       Date:  2021-09-08       Impact factor: 5.275

Review 5.  Lung cancer stem cells: progress and prospects.

Authors:  Amber Lundin; Barbara Driscoll
Journal:  Cancer Lett       Date:  2012-08-17       Impact factor: 8.679

6.  POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expression.

Authors:  Yan-hong Xin; Bai-shi-jiao Bian; Xiao-jun Yang; Wei Cui; Hong-juan Cui; You-hong Cui; Xia Zhang; Chuan Xu; Xiu-wu Bian
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

Review 7.  Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells.

Authors:  Geeta Upadhyay
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

8.  Genome-Wide and Phenotypic Evaluation of Stem Cell Progenitors Derived From Gprc5a-Deficient Murine Lung Adenocarcinoma With Somatic Kras Mutations.

Authors:  Reem Daouk; Maya Hassane; Hisham F Bahmad; Ansam Sinjab; Junya Fujimoto; Wassim Abou-Kheir; Humam Kadara
Journal:  Front Oncol       Date:  2019-04-02       Impact factor: 6.244

9.  Detection of circulating natural antibodies against CD25, MUC1, and VEGFR1 for early diagnosis of non-small cell lung cancer.

Authors:  Siqi Liu; Xuan Zhang; Quanhang Jiang; Tingting Liang
Journal:  FEBS Open Bio       Date:  2020-05-25       Impact factor: 2.693
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.